In last trading session, Compugen Ltd. (NASDAQ:CGEN) saw 0.42 million shares changing hands with its beta currently measuring 2.44. Company’s recent per share price level of $0.96 trading at $0.04 or 4.27% at ring of the bell on the day assigns it a market valuation of $85.65M. That closing price of CGEN’s stock is at a discount of -408.33% from its 52-week high price of $4.88 and is indicating a premium of 46.87% from its 52-week low price of $0.51. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.7 million shares which gives us an average trading volume of 1.02 million if we extend that period to 3-months.
For Compugen Ltd. (CGEN), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.70. Splitting up the data highlights that, out of 7 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 6 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.1 in the current quarter.
Compugen Ltd. (NASDAQ:CGEN) trade information
Upright in the green during last session for gaining 4.27%, in the last five days CGEN remained trading in the green while hitting it’s week-highest on Friday, 11/18/22 when the stock touched $0.96 price level, adding 14.29% to its value on the day. Compugen Ltd.’s shares saw a change of -77.67% in year-to-date performance and have moved 7.76% in past 5-day. Compugen Ltd. (NASDAQ:CGEN) showed a performance of 21.52% in past 30-days. Number of shares sold short was 2.83 million shares which calculate 2.65 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $6.29 to the stock, which implies a rise of 84.74% to its current value. Analysts have been projecting $1.00 as a low price target for the stock while placing it at a high target of $14.00. It follows that stock’s current price would drop -1358.33% in reaching the projected high whereas dropping to the targeted low would mean a loss of -4.17% for stock’s current value.
Compugen Ltd. (CGEN) estimates and forecasts
Statistics highlight that Compugen Ltd. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -44.51% of value to its shares in past 6 months, showing an annual growth rate of -17.07% while that of industry is 4.60. Apart from that, the company came lowering its revenue forecast for fiscal year 2022.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 8.10% during past 5 years.
Compugen Ltd. is more likely to be releasing its next quarterly report between February 22 and February 27 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Compugen Ltd. (NASDAQ:CGEN)’s Major holders
Insiders are in possession of 5.68% of company’s total shares while institution are holding 26.29 percent of that, with stock having share float percentage of 27.88%. Investors also watch the number of corporate investors in a company very closely, which is 26.29% institutions for Compugen Ltd. that are currently holding shares of the company. Nikko Asset Management Americas, Inc. is the top institutional holder at CGEN for having 6.36 million shares of worth $11.77 million. And as of Jun 29, 2022, it was holding 7.35% of the company’s outstanding shares.
The second largest institutional holder is Vanguard Group, Inc. (The), which was holding about 2.42 million shares on Jun 29, 2022. The number of shares represents firm’s hold over 2.79% of outstanding shares, having a total worth of $4.48 million.
On the other hand, ARK ETF Tr-ARK Israel Innovative Technology ETF and Vanguard International Stock Index-Total Intl Stock Indx are the top two Mutual Funds which own company’s shares. As of Sep 29, 2022, the former fund manager was holding 1.16 million shares of worth $0.76 million or 1.34% of the total outstanding shares. The later fund manager was in possession of 1.0 million shares on Jul 30, 2022, making its stake of worth around $1.61 million in the company or a holder of 1.15% of company’s stock.